nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—Nocturia—Varenicline—nicotine dependence	0.03	0.0332	CcSEcCtD
Acebutolol—Abnormal dreams—Varenicline—nicotine dependence	0.0275	0.0305	CcSEcCtD
Acebutolol—Dry eye—Varenicline—nicotine dependence	0.0257	0.0285	CcSEcCtD
Acebutolol—Disorientation—Varenicline—nicotine dependence	0.0226	0.025	CcSEcCtD
Acebutolol—Eye pain—Varenicline—nicotine dependence	0.0224	0.0248	CcSEcCtD
Acebutolol—Hot flush—Varenicline—nicotine dependence	0.0216	0.0239	CcSEcCtD
Acebutolol—Amnesia—Varenicline—nicotine dependence	0.0215	0.0238	CcSEcCtD
Acebutolol—Menopausal symptoms—Varenicline—nicotine dependence	0.0214	0.0237	CcSEcCtD
Acebutolol—Visual disturbance—Varenicline—nicotine dependence	0.0213	0.0236	CcSEcCtD
Acebutolol—Lethargy—Varenicline—nicotine dependence	0.0206	0.0228	CcSEcCtD
Acebutolol—Affect lability—Varenicline—nicotine dependence	0.0199	0.022	CcSEcCtD
Acebutolol—Psychotic disorder—Varenicline—nicotine dependence	0.0197	0.0219	CcSEcCtD
Acebutolol—Mood swings—Varenicline—nicotine dependence	0.0192	0.0212	CcSEcCtD
Acebutolol—Erectile dysfunction—Varenicline—nicotine dependence	0.0161	0.0178	CcSEcCtD
Acebutolol—Weight increased—Varenicline—nicotine dependence	0.0159	0.0176	CcSEcCtD
Acebutolol—Depression—Varenicline—nicotine dependence	0.0155	0.0172	CcSEcCtD
Acebutolol—Conjunctivitis—Varenicline—nicotine dependence	0.0151	0.0168	CcSEcCtD
Acebutolol—Bradycardia—Varenicline—nicotine dependence	0.0142	0.0158	CcSEcCtD
Acebutolol—Hallucination—Varenicline—nicotine dependence	0.0139	0.0154	CcSEcCtD
Acebutolol—Hypoaesthesia—Varenicline—nicotine dependence	0.0139	0.0154	CcSEcCtD
Acebutolol—Connective tissue disorder—Varenicline—nicotine dependence	0.0137	0.0152	CcSEcCtD
Acebutolol—Visual impairment—Varenicline—nicotine dependence	0.0135	0.0149	CcSEcCtD
Acebutolol—Tinnitus—Varenicline—nicotine dependence	0.013	0.0144	CcSEcCtD
Acebutolol—Angiopathy—Varenicline—nicotine dependence	0.0127	0.0141	CcSEcCtD
Acebutolol—Mediastinal disorder—Varenicline—nicotine dependence	0.0126	0.014	CcSEcCtD
Acebutolol—Chills—Varenicline—nicotine dependence	0.0126	0.0139	CcSEcCtD
Acebutolol—Flatulence—Varenicline—nicotine dependence	0.012	0.0133	CcSEcCtD
Acebutolol—Back pain—Varenicline—nicotine dependence	0.0118	0.013	CcSEcCtD
Acebutolol—Vision blurred—Varenicline—nicotine dependence	0.0115	0.0127	CcSEcCtD
Acebutolol—Ill-defined disorder—Varenicline—nicotine dependence	0.0113	0.0125	CcSEcCtD
Acebutolol—Malaise—Varenicline—nicotine dependence	0.011	0.0122	CcSEcCtD
Acebutolol—Vertigo—Varenicline—nicotine dependence	0.0109	0.0121	CcSEcCtD
Acebutolol—Syncope—Varenicline—nicotine dependence	0.0109	0.0121	CcSEcCtD
Acebutolol—Palpitations—Varenicline—nicotine dependence	0.0108	0.0119	CcSEcCtD
Acebutolol—Loss of consciousness—Varenicline—nicotine dependence	0.0107	0.0119	CcSEcCtD
Acebutolol—Cough—Varenicline—nicotine dependence	0.0106	0.0118	CcSEcCtD
Acebutolol—Chest pain—Varenicline—nicotine dependence	0.0104	0.0115	CcSEcCtD
Acebutolol—Myalgia—Varenicline—nicotine dependence	0.0104	0.0115	CcSEcCtD
Acebutolol—Arthralgia—Varenicline—nicotine dependence	0.0104	0.0115	CcSEcCtD
Acebutolol—Anxiety—Varenicline—nicotine dependence	0.0103	0.0114	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.0103	0.0114	CcSEcCtD
Acebutolol—Discomfort—Varenicline—nicotine dependence	0.0102	0.0113	CcSEcCtD
Acebutolol—Oedema—Varenicline—nicotine dependence	0.00994	0.011	CcSEcCtD
Acebutolol—Shock—Varenicline—nicotine dependence	0.00978	0.0108	CcSEcCtD
Acebutolol—Nervous system disorder—Varenicline—nicotine dependence	0.00975	0.0108	CcSEcCtD
Acebutolol—Skin disorder—Varenicline—nicotine dependence	0.00965	0.0107	CcSEcCtD
Acebutolol—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00964	0.0995	CbGpPWpGaD
Acebutolol—Hyperhidrosis—Varenicline—nicotine dependence	0.00961	0.0106	CcSEcCtD
Acebutolol—Anorexia—Varenicline—nicotine dependence	0.00947	0.0105	CcSEcCtD
Acebutolol—Hypotension—Varenicline—nicotine dependence	0.00929	0.0103	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00905	0.01	CcSEcCtD
Acebutolol—Insomnia—Varenicline—nicotine dependence	0.00899	0.00995	CcSEcCtD
Acebutolol—Dyspnoea—Varenicline—nicotine dependence	0.00886	0.00981	CcSEcCtD
Acebutolol—Somnolence—Varenicline—nicotine dependence	0.00883	0.00978	CcSEcCtD
Acebutolol—Dyspepsia—Varenicline—nicotine dependence	0.00875	0.00969	CcSEcCtD
Acebutolol—Decreased appetite—Varenicline—nicotine dependence	0.00864	0.00957	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00858	0.0095	CcSEcCtD
Acebutolol—Fatigue—Varenicline—nicotine dependence	0.00857	0.00949	CcSEcCtD
Acebutolol—Constipation—Varenicline—nicotine dependence	0.0085	0.00941	CcSEcCtD
Acebutolol—Pain—Varenicline—nicotine dependence	0.0085	0.00941	CcSEcCtD
Acebutolol—Feeling abnormal—Varenicline—nicotine dependence	0.00819	0.00907	CcSEcCtD
Acebutolol—Gastrointestinal pain—Varenicline—nicotine dependence	0.00813	0.009	CcSEcCtD
Acebutolol—Urticaria—Varenicline—nicotine dependence	0.00789	0.00874	CcSEcCtD
Acebutolol—Abdominal pain—Varenicline—nicotine dependence	0.00786	0.0087	CcSEcCtD
Acebutolol—Body temperature increased—Varenicline—nicotine dependence	0.00786	0.0087	CcSEcCtD
Acebutolol—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00752	0.0776	CbGpPWpGaD
Acebutolol—Asthenia—Varenicline—nicotine dependence	0.00713	0.0079	CcSEcCtD
Acebutolol—Pruritus—Varenicline—nicotine dependence	0.00703	0.00779	CcSEcCtD
Acebutolol—Diarrhoea—Varenicline—nicotine dependence	0.0068	0.00753	CcSEcCtD
Acebutolol—Dizziness—Varenicline—nicotine dependence	0.00657	0.00728	CcSEcCtD
Acebutolol—Vomiting—Varenicline—nicotine dependence	0.00632	0.007	CcSEcCtD
Acebutolol—Rash—Varenicline—nicotine dependence	0.00627	0.00694	CcSEcCtD
Acebutolol—Dermatitis—Varenicline—nicotine dependence	0.00626	0.00693	CcSEcCtD
Acebutolol—Headache—Varenicline—nicotine dependence	0.00623	0.00689	CcSEcCtD
Acebutolol—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00598	0.0617	CbGpPWpGaD
Acebutolol—Nausea—Varenicline—nicotine dependence	0.0059	0.00654	CcSEcCtD
Acebutolol—ADRB1—Monoamine GPCRs—DRD2—nicotine dependence	0.00386	0.0399	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—DRD2—nicotine dependence	0.00378	0.039	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00325	0.0335	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00318	0.0328	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0025	0.0258	CbGpPWpGaD
Acebutolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00248	0.0256	CbGpPWpGaD
Acebutolol—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00245	0.0253	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00237	0.0245	CbGpPWpGaD
Acebutolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00201	0.0208	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—CHRNB3—nicotine dependence	0.00192	0.0198	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—CHRNA6—nicotine dependence	0.00182	0.0188	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00171	0.0177	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00164	0.017	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—TAS2R16—nicotine dependence	0.0016	0.0165	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00156	0.0161	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00153	0.0158	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—GABRA4—nicotine dependence	0.00131	0.0136	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—CHRNB4—nicotine dependence	0.00126	0.013	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00125	0.0129	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—CHRNA5—nicotine dependence	0.00117	0.0121	CbGpPWpGaD
Acebutolol—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00113	0.0117	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.0011	0.0113	CbGpPWpGaD
Acebutolol—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00107	0.011	CbGpPWpGaD
Acebutolol—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00105	0.0109	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00103	0.0106	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00101	0.0104	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000996	0.0103	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—CHRNA3—nicotine dependence	0.000955	0.00985	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000902	0.00931	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000884	0.00912	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000883	0.00911	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000865	0.00892	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.00084	0.00867	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000819	0.00846	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000802	0.00827	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.000763	0.00788	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000746	0.0077	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00073	0.00753	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—FGD1—nicotine dependence	0.000708	0.00731	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000706	0.00729	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—FGD1—nicotine dependence	0.000693	0.00715	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—OPRM1—nicotine dependence	0.000673	0.00695	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—OPRM1—nicotine dependence	0.000658	0.00679	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—FGD1—nicotine dependence	0.000643	0.00664	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000639	0.00659	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—FGD1—nicotine dependence	0.000629	0.00649	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000625	0.00645	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—DRD2—nicotine dependence	0.000487	0.00502	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TAS2R16—nicotine dependence	0.000484	0.005	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—DRD2—nicotine dependence	0.000476	0.00491	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TAS2R16—nicotine dependence	0.000473	0.00489	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000414	0.00427	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—OPRM1—nicotine dependence	0.00038	0.00393	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGD1—nicotine dependence	0.00038	0.00392	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000372	0.00384	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGD1—nicotine dependence	0.000372	0.00383	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—OPRM1—nicotine dependence	0.000345	0.00356	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—OPRM1—nicotine dependence	0.000338	0.00349	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKR1B10—nicotine dependence	0.000336	0.00346	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CYP2A7—nicotine dependence	0.000331	0.00341	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKR1B10—nicotine dependence	0.000328	0.00339	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—DRD2—nicotine dependence	0.000275	0.00284	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—DRD2—nicotine dependence	0.000269	0.00278	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—DRD2—nicotine dependence	0.00025	0.00258	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—DRD2—nicotine dependence	0.000244	0.00252	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—WASF2—nicotine dependence	0.000236	0.00244	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—WASF2—nicotine dependence	0.000231	0.00239	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—WASF1—nicotine dependence	0.000227	0.00234	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—WASF1—nicotine dependence	0.000222	0.00229	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—OPRM1—nicotine dependence	0.000204	0.00211	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—OPRM1—nicotine dependence	0.0002	0.00206	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000194	0.002	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000183	0.00189	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DRD2—nicotine dependence	0.000148	0.00152	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DRD2—nicotine dependence	0.000144	0.00149	CbGpPWpGaD
